Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Belldegrun

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Urology|November 1, 1993
Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinomaA Belldegrun, W Pierce, R Kaboo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinomaP Mulders, C L Tso, S Pang, et al.
Transfusion|September 1, 1993
Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factorsL D Petz, L Calhoun, P Yam, et al.
The Journal of Urology|November 1, 1996
Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patientsM H Sokoloff, C L Tso, R Kaboo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacyP J Rosen, E F Mendoza, E M Landaw, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinomaG G Steger, M F Gnant, M P Djavanmard, et al.
Cancer Gene Therapy|January 1, 1996
In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vectorE M Toloza, K Hunt, S Swisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccinesP Mulders, C L Tso, B Gitlitz, et al.
Journal of the National Cancer Institute|February 3, 1993
Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccinesA Belldegrun, C L Tso, T Sakata, et al.
Neurosurgical Focus|July 5, 2006
Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case ReportL M Liau, K L Black, N A Martin, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Urology|November 1, 1993
Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinomaA Belldegrun, W Pierce, R Kaboo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinomaP Mulders, C L Tso, S Pang, et al.
Transfusion|September 1, 1993
Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factorsL D Petz, L Calhoun, P Yam, et al.
The Journal of Urology|November 1, 1996
Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patientsM H Sokoloff, C L Tso, R Kaboo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacyP J Rosen, E F Mendoza, E M Landaw, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinomaG G Steger, M F Gnant, M P Djavanmard, et al.
Cancer Gene Therapy|January 1, 1996
In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vectorE M Toloza, K Hunt, S Swisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccinesP Mulders, C L Tso, B Gitlitz, et al.
Journal of the National Cancer Institute|February 3, 1993
Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccinesA Belldegrun, C L Tso, T Sakata, et al.
Neurosurgical Focus|July 5, 2006
Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case ReportL M Liau, K L Black, N A Martin, et al.
Pageof 13